680 results on '"Pardi, Darrell S."'
Search Results
2. Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
3. Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care
4. Inflammatory Bowel Disease: Therapy
5. Delayed Acute Pancreatitis After Transpapillary Gallbladder Drainage With Plastic Stents
6. Reduction in urinary tract infections in patients treated with fecal microbiota transplantation for recurrent Clostridioides difficile infection
7. Update on the Epidemiology and Management of Microscopic Colitis
8. Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing
9. Effectiveness of Bile Acid Sequestrants in Microscopic Colitis and Utility of Bile Acid Testing: A Systematic Review and Meta-Analysis
10. Clinical Characteristics and Treatment Response in Microscopic Colitis Based on Age at Diagnosis: A Multicenter Retrospective Study
11. Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium
12. The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019
13. Microscopic Colitis and Risk of Colon Adenomas: A Multicenter Retrospective Cohort Study
14. Efficacy and Safety of Vedolizumab and Tumor Necrosis Factor Inhibitors in the Treatment of Steroid-refractory Microscopic Colitis: A Systematic Review and Meta-analysis.
15. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium
16. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium
17. Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis.
18. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
19. Reply
20. S77 Safety and Efficacy of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Older Patients With Recurrent Clostridioides difficile Infection: Findings From an Integrated Analysis of Phase 3 Trials
21. Microscopic colitis
22. Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis
23. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group
24. S244 Open Label Experience With Bismuth Subsalicylate in Patients With Microscopic Colitis
25. S753 Clinical, Endoscopic and Histologic Features of Common Variable Immunodeficiency
26. S207 Predictive Machine Learning Models for Recurrent C. difficile Infection in Inflammatory Bowel Disease Patients Based on First-Episode CDI Treatment
27. S2404 Clinical Manifestations of Sclerosing Mesenteritis: A Case Series
28. S233 Clinical Outcomes and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis
29. S208 A Machine Learning Model for Predicting Recurrent C. difficile Infection in Patients With Inflammatory Bowel Disease (Recur CDI-IBD)
30. S206 Predicting Recurrent C. difficile Infection in IBD Patients: An Application of AutoML Tabular and Text Classification Models on Electronic Health Records and Clinical Notes
31. S3329 Delayed Acute Pancreatitis After Transpapillary Gallbladder Drainage With Plastic Stents, A Case Series
32. Efficacy and Safety of Vedolizumab and Tumor Necrosis Factor Inhibitors in the Treatment of Steroid-refractory Microscopic Colitis
33. Low Risk of Primary Clostridium difficile Infection With Tetracyclines : A Systematic Review and Metaanalysis
34. Reply to Davido et al
35. Microscopic Colitis, Collagenous and Lymphocytic
36. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases
37. Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis
38. Non–Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease
39. Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
40. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency
41. Use of Anti–Tumor Necrosis Factors and Anti-Integrins in the Treatment of Crohn's Disease
42. Experience and Outcomes at a Specialized Clostridium difficile Clinical Practice
43. Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression
44. The surgical management of inflammatory bowel disease
45. Chronic Diarrhea: Diagnosis and Management
46. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease
47. Clostridium difficile Infection in the Emergency Department
48. Chronic Diarrhea
49. Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center
50. VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.